Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

enough consolidating between >40 and .43....need to get

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Med.rare Member Profile
Member Level 
Followed By 22
Posts 2,484
Boards Moderated 1
Alias Born 03/28/01
160x600 placeholder
Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Eval... "GlobeNewswire Inc." - 1/9/2018 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/8/2018 8:17:32 AM
Inovio Receives Milestone Payment from MedImmune as MEDI0457 and Checkpoint Inhibitor Combination Trial in Head and Neck Squa... "GlobeNewswire Inc." - 1/8/2018 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/2/2018 4:07:26 PM
Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in Greater China "GlobeNewswire Inc." - 1/2/2018 8:00:00 AM
Inovio Pharmaceuticals Promotes Dr. Laurent Humeau to Senior Vice President, Research & Development "GlobeNewswire Inc." - 12/11/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/6/2017 2:08:10 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 12/6/2017 2:06:14 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/6/2017 1:58:14 PM
Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors "GlobeNewswire Inc." - 12/6/2017 8:00:00 AM
Inovio’s Further Analysis of VGX-3100 Phase 2b Data Reveals Immune Correlates and Biomarker Signatures That Predicted Clini... "GlobeNewswire Inc." - 11/29/2017 8:00:00 AM
Inovio Pharmaceuticals SynCon® TERT Cancer Immunotherapy Combined with Checkpoint Inhibitor Synergistically Shrinks Tumor a... "GlobeNewswire Inc." - 11/27/2017 8:00:00 AM
Inovio Pharmaceuticals Presents Immuno-Oncology Advancements At Society for Immunotherapy of Cancer Conference "GlobeNewswire Inc." - 11/10/2017 10:27:55 AM
Inovio Pharmaceuticals to Participate In Upcoming Investment Conferences "GlobeNewswire Inc." - 11/9/2017 8:00:00 AM
Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results "GlobeNewswire Inc." - 11/8/2017 4:05:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/8/2017 3:58:49 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/2/2017 6:07:10 AM
Inovio Pharmaceuticals Initiates Immuno-Oncology Clinical Study for Glioblastoma in Combination with Regeneron’s PD-1 Inhi... "GlobeNewswire Inc." - 11/1/2017 9:18:26 AM
Inovio Pharmaceuticals to Report Third Quarter 2017 Financial Results on November 8, 2017 "GlobeNewswire Inc." - 10/26/2017 8:00:00 AM
Inovio and U.S. Army Co-developing Novel Vaccine That Completely Prevents Lethal Lassa Fever Infection in Pre-Clinical Study... "GlobeNewswire Inc." - 10/24/2017 8:00:00 AM
Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inh... "GlobeNewswire Inc." - 10/16/2017 7:00:00 AM
Inovio’s Positive Zika Vaccine Clinical Study Data Published in New England Journal of Medicine "GlobeNewswire Inc." - 10/5/2017 7:00:00 AM
Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant Bacterial Infection In Prec... "GlobeNewswire Inc." - 9/21/2017 8:00:00 AM
Inovio and Partners Initiate Phase 1/2a Clinical Trial To Further Advance Its Vaccine Against Deadly MERS Infection "GlobeNewswire Inc." - 9/18/2017 8:00:00 AM
Inovio’s Cancer Immunotherapy (INO-5150) Slowed PSA Rise and Significantly Increased PSA Doubling Times In Patients with R... "GlobeNewswire Inc." - 9/11/2017 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist